Testing a new medication to slow nerve damage in ALS

This trial is testing a medication called dazucorilant to see if it can help slow the progression of ALS, a disease that affects the nerve cells that control muscle movement. The study will compare this medication at two different doses against a placebo (a pill with no active medicine) to understand how well it works and how safe it is. Participants will take the medication by mouth once daily for several months.

ALS is a serious disease that gradually weakens muscles and limits movement, and there are very few treatment options available. This trial is exploring whether this medication might help protect nerve cells and slow down how quickly the disease progresses, offering patients another treatment choice.